statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 Compugen to...

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of...

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Key Insights Compugen's estimated fair value is US$3.61 based on 2 Stage Free Cash Flow to Equity Compugen's US$2.32...

Is Compugen Ltd. (NASDAQ:CGEN) Trading At A 36% Discount?

Compugen Ltd. (NASDAQ:CGEN - Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.57 and traded...

Compugen (NASDAQ:CGEN) Shares Cross Above 200-Day Moving Average of $1.57

Compugen to Participate in Two Upcoming Investor Conferences Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel, April 3, 2024 HOLON, Israel, April 3, 2024...

Compugen to Participate in Two Upcoming Investor Conferences

Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy PR...

Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy

Q4 2023 Compugen Ltd Earnings Call Transcript

Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 PR Newswire HOLON...

Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Compugen reports Q4 EPS 11c, consensus 22c

Compugen Reports Fourth Quarter and Full Year 2023 Results Compugen Reports Fourth Quarter and Full Year 2023 Results PR Newswire HOLON, Israel, March 5, 2024 Partnership with Gilead on preclinical...

Compugen Reports Fourth Quarter and Full Year 2023 Results

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Volume	326,170.00
52-Wk High	$3.03
52-Wk Low	$0.53

CGEN Compugen Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals